# Suicide Gene Therapy Trial

> **NCT01204502** · PHASE1,PHASE2 · TERMINATED · sponsor: **Great Ormond Street Hospital for Children NHS Foundation Trust** · enrollment: 2 (actual)

## Conditions studied

- Haploidentical Stem Cell Transplantation

## Interventions

- **BIOLOGICAL:** HSVTK retrovirally-transduced donor T lymphocytes

## Key facts

- **NCT ID:** NCT01204502
- **Lead sponsor:** Great Ormond Street Hospital for Children NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Changes in the clinical practice
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01204502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01204502, "Suicide Gene Therapy Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01204502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*